• Home
  • PR

PR

News

게시물 상세
OliX Pharmaceuticals to Conduct One-on-One Meetings at BIO-Europe Digital 2021 Conference
Date : 2022-03-22     View : 324

 

OliX Pharmaceuticals to Conduct One-on-One Meetings at BIO-Europe Digital 2021 Conference

 

 

Suwon, Republic of Korea, October 21, 2021OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will hold one-on-one partnering meetings at BIO-Europe Digital 2021, being held virtually October 25-28, 2021.

 

Sun Woo Hong, Ph.D., head of R&D at OliX Pharmaceuticals, and June Hyun Park, Ph.D., principal scientist at OliX Pharmaceuticals, will be available to discuss platform-based early discovery collaborations as well as global licensing options for the Company’s pipeline programs for OLX703A for hepatitis B virus (HBV), OLX104C for androgenic alopecia (hair loss) and OLX702A for non-alcoholic steatohepatitis (NASH).

 

To schedule a virtual meeting, please visit the BIO-Europe partneringONE® platform here: https://informaconnect.com/bioeurope/partnering/

 

 

 

Prev OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board
Next OliX Pharmaceuticals Enters Agreement with Pharmaron